Anvaya Media Works Logo

Annual
Report

Innovating Today
Improving Lives Tomorrow

₹0 CrRevenue
₹0 CrEBITDA
0%Revenue Growth
0+Markets Served
FY 2026
Annual Report

What's Inside

Company at a Glance03

FY 2025-26 highlights and our business

Business Performance04

Financial results and key growth drivers

Operations & Innovation05

Manufacturing, R&D and therapeutic focus

Financial Summary06

Key figures and revenue mix

Looking Ahead07

2026-27 priorities and next milestone

What's Inside Overview
02

Company at a Glance

A research-driven pharmaceutical company focused on developing and delivering quality healthcare solutions across key therapeutic areas.

₹0 CrRevenue
₹0 CrEBITDA
0%Revenue growth
0+Markets served

Our Business

Research & Development
Manufacturing
Pharmaceutical Products
Market Access

Our Purpose

Improving lives through accessible, reliable healthcare.

Company Building

Business Performance

The company delivered consistent financial and operational performance during FY 2025-26, supported by portfolio expansion and stronger market presence.

Business Performance

Key Financials

₹0 CrRevenue
₹0 CrEBITDA
₹0 CrProfit after tax
0%Revenue growth

Key Drivers

Portfolio ExpansionNew products strengthened our therapeutic portfolio
Market GrowthExpanded presence across selected international markets
Operational EfficiencyImproved manufacturing and supply-chain performance

Operations & Innovation

Our operations combine pharmaceutical expertise, manufacturing capabilities and focused research to support long-term growth.

0Manufacturing facilities
0Key product launches
0+R&D professionals
0Therapeutic areas

Our Focus Areas

Cardiology
Diabetes Care
Respiratory Health
Pain Management
Gastroenterology
Specialty Care

Innovation

Research
Develop
Deliver

Continued investment in product development, process improvement and scientific capabilities.

Operations and Innovation

Financial Summary

Key financial and operational indicators for FY 2025-26, along with the split of revenue between domestic and international business.

Financial Summary
₹0 CrRevenue
₹0 CrEBITDA
₹0 CrProfit After Tax
0%Revenue Growth
0Manufacturing Facilities
0+Markets Served
0+R&D Professionals

Revenue Mix

Domestic Business
62%
International Business
38%

Looking Ahead

The company enters the next financial year focused on expanding its portfolio, strengthening market presence and improving operational capabilities.

2026-27 Priorities

01
Expand selected international marketsDeepening presence in priority markets
02
Strengthen product portfolioAdding to our therapeutic offering
03
Increase R&D capabilitiesInvesting in scientific talent and capacity
04
Improve operational efficiencyStreamlining manufacturing and supply chain

Our Next Milestone

₹0 CrRevenue ambition
0+Markets targeted
0+New product opportunities
Looking Ahead
Full Financial Report

Ready to explore our complete Annual Report?

Download the official publication with in-depth financial disclosures, operational highlights, and forward-looking growth roadmaps.

Measure Improve Progress
MEASUREIMPROVEPROGRESS
Report Locked at 30%

Unlock the Full Annual Report

Submit the form above to unlock the full report and access complete financial tables, operational breakdowns, and strategic roadmaps.